{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:52:40Z","timestamp":1756385560976},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,26]],"date-time":"2006-06-26T00:00:00Z","timestamp":1151280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>In patients with steroid\u2010refractory Crohn's disease, the therapeutic goal is to achieve both rapid remission and maintenance of clinical response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the long\u2010term benefit in patients treated with cyclophosphamide pulse therapy and azathioprine or methotrexate, a combination shown to be effective in a recent pilot study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixteen patients with acute steroid\u2010refractory Crohn's disease participated in a prospective open\u2010labelled uncontrolled pilot study between December 1998 and June 2003. All had a median number of 4\u2003monthly pulses of intravenous cyclophosphamide (750\u2003mg) and were followed until relapse of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirteen of 16 patients (81%) achieved remission within 8\u2003weeks after two pulses of cyclophosphamide in combination with azathioprine or methotrexate, with a Crohn's Disease Activity Index decrease from 294 to 111 (median). Remission sustained for 19\u2003months (median, range: 1\u201345). Moreover, eight patients with pyoderma gangrenosum and erythema nodosum who responded to cyclophosphamide have maintained their remission for up to 30\u2003months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In steroid refractory patients with Crohn's disease, cyclophosphamide is highly effective to induce remission. This uncontrolled study indicates that cyclophosphamide\u2010induced remission is long\u2010lasting under standard immunosuppressive therapy.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.02988.x","type":"journal-article","created":{"date-parts":[[2006,6,26]],"date-time":"2006-06-26T15:49:50Z","timestamp":1151336990000},"page":"343-350","source":"Crossref","is-referenced-by-count":23,"title":["Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long\u2010term remission in patients with steroid\u2010refractory Crohn's disease"],"prefix":"10.1111","volume":"24","author":[{"given":"C.","family":"SCHMIDT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"WITTIG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"MOSER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"ZEITZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"STALLMACH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(79)90385-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0016-5085(84)90409-8","article-title":"European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment","volume":"86","author":"Malchow H","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90337-C"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808063390603"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.3.360"},{"key":"e_1_2_6_7_2","first-page":"CD000067","article-title":"Azathioprine for maintaining remission of Crohn's disease","volume":"2","author":"Pearson DC","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90277-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10374"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834010-00004"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80741-4"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical application","volume":"5","author":"Colvin OM","year":"1999","journal-title":"Curr Pharm Des"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80193-0"},{"key":"e_1_2_6_17_2","first-page":"76","article-title":"Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide","volume":"53","author":"Lacki JK","year":"1994","journal-title":"Z Rheumatol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.3.377"},{"key":"e_1_2_6_19_2","first-page":"287","article-title":"Pyoderma gangrenosum","volume":"68","author":"Blitz NM","year":"2001","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-36670"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603063141004"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.42.4.368"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90490-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90367-M"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339700600307"},{"key":"e_1_2_6_26_2","first-page":"694","article-title":"Infections in systemic lupus erythematosus patients","volume":"26","author":"Paton NI","year":"1997","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200309000-00002"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401213"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.6.659"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.02988.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.02988.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:21:30Z","timestamp":1697181690000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.02988.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,26]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1365-2036.2006.02988.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02988.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,26]]}}}